jazyk / language:
INTERAKTÍVNA KONFERENCIA
MLADÝCH VEDCOV
Späť do sekcie

New immunohistochemical prognostic factor of uveal melanoma

Diskusná interakcia
Celkové prevedenie (dizajn)
Vedecká práca
Zobraziť všetky hodnotenia

Prejsť do diskusie

New immunohistochemical prognostic factor of uveal melanoma

Zuzana Svetlošáková 1 Hana Gergišáková 2 Alena Furdová 1

1Department of Ophthalmology, University Hospital Ruzinov, Bratislava, Slovakia
2Department od Pathological anatomy Comenius University in Bratislava, Faculty of Medicine, Bratislava, Slovakia
zuzana.svetlosakova@gmail.com

Apoptosis-inducing factor (AIF) is a mitochondrial protein, which plays an important role in the caspase-independent apoptosis and has also an oxidoreductase function. The expression of AIF in uveal melanoma and its possible impact on patients` prognosis is unkonwn. The aim of our study was to evaluate the expression of AIF in uveal melanoma cells and to assess its predictive value.

We performed a retrospective study of 54 patients with choroidal or ciliary body melanoma treated surgically (enucleation, endoresection) at our clinic during the years 2001 - 2007. Patients` mortality was assessed to August 30th 2012.  Immunohistochemical evaluation of AIF expression using polyclonal rabbit antibody in formalin-fixed paraffin embedded melanoma tissue was performed.

Histological samples of 49 patients were assessed. During the follow-up of 60 ± 36 months there was a significantly higher mortality in patients with ≥ 70% of immunopositive cells in the histological sample comparing to those with lower or none AIF expression (70,4% vs. 40,9%, P=0,038), while there was no significant difference in known conventional prognostic factors (mean age, tumor size or histopathological type of tumor) between the compared groups.

Our study shows that high level of AIF expression in uveal melanoma cells is associated with unfavourable prognosis. The role of AIF as a prognostic factor in uveal melanoma will need confirmation in larger and prospective studies.

Zdá sa, že Váš internetový prehliadač nepodporuje prehliadanie PDF dokumentov.
Pre zobrazenie súboru je potrebné maš nainštalovaný Adobe Reader.

Diskusia

Otázky 09.05.2014 15:51
Dobrý deň pani doktorka! Chcela by som sa Vás opýtať, že prečo ste vybrali práve AIF vo Vašej štúdii? Uvádzate, že neboli zmeny vo veku, veľkosti tumoru a histologickom type medzi dvoma skupina...Zobraziť celý komentár
Naši partneri
Generálny partner

Partneri
Špeciálne poďakovanie
Mediálni partneri
Inzercia zadarmo
Usporiadateľ